GlassScriptPhysician profile
Daniel Allan Buckingham
NPI 1992732028
$501.80
in general payments reported to CMS, 2019-2025
17 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.24 · 2020: $64.55 · 2021: $89.31 · 2022: $95.64 · 2023: $18.40 · 2024: $29.01 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $82.22 | 2019-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $64.13 | 2019-2022 | |
| Amgen INC. | $59.58 | 2020-2021 | |
| Harmony Biosciences LLC | $48.99 | 2025 | |
| Abbott Laboratories | $34.42 | 2022-2023 | Freestyle Libre 3 |
| Indivior INC. | $29.01 | 2024 | Sublocade |
| Glaxosmithkline, LLC. | $26.63 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $20.36 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.48 | 2022 | |
| Boston Scientific Corporation | $17.50 | 2025 | Watchman Flx |
| Dexcom, INC. | $16.03 | 2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $15.45 | 2022 | |
| Currax Pharmaceuticals LLC | $15.05 | 2021 | |
| Lundbeck LLC | $14.35 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.07 | 2025 | Givlaari |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.39 | 2019 | |
| Medtronic Minimed, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Buckingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.